相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Combined activity of COX-1 and COX-2 is increased in non-neoplastic colonic mucosa from colorectal neoplasia patients
Thorbjorn Soren Ronn Jensen et al.
BMC GASTROENTEROLOGY (2018)
Acetylcholine-related proteins in non-neoplastic appearing colonic mucosa from patients with colorectal neoplasia
Morten Matthiesen Bach Damm et al.
MOLECULAR CARCINOGENESIS (2017)
Phosphodiesterases in non-neoplastic appearing colonic mucosa from patients with colorectal neoplasia
Badar Mahmood et al.
BMC CANCER (2016)
Prostaglandin E2 and the EP receptors in malignancy: possible therapeutic targets?
G. O'Callaghan et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
ERKs in Cancer: Friends or Foes?
Xavier Deschenes-Simard et al.
CANCER RESEARCH (2014)
Phosphatase: PP2A structural importance, regulation and its aberrant expression in cancer
Parthasarathy Seshacharyulu et al.
CANCER LETTERS (2013)
Tumor suppressor activity of the ERK/MAPK pathway by promoting selective protein degradation
Xavier Deschenes-Simard et al.
GENES & DEVELOPMENT (2013)
Transporter function and cyclic AMP turnover in normal colonic mucosa from patients with and without colorectal neoplasia
Karen Kleberg et al.
BMC GASTROENTEROLOGY (2012)
Sef Downregulation by Ras Causes MEK1/2 to Become Aberrantly Nuclear Localized Leading to Polyploidy and Neoplastic Transformation
Stephanie Duhamel et al.
CANCER RESEARCH (2012)
Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
Haoqiang Ying et al.
CELL (2012)
Distinct ATOH1 and Neurog3 requirements define tuft cells as a new secretory cell type in the intestinal epithelium
Francois Gerbe et al.
JOURNAL OF CELL BIOLOGY (2011)
International Union of Basic and Clinical Pharmacology. LXXXIII: Classification of Prostanoid Receptors, Updating 15 Years of Progress
D. F. Woodward et al.
PHARMACOLOGICAL REVIEWS (2011)
Prostaglandin E2-induced colonic secretion in patients with and without colorectal neoplasia
Nicolai Kaltoft et al.
BMC GASTROENTEROLOGY (2010)
The PI3K Pathway As Drug Target in Human Cancer
Kevin D. Courtney et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Activation of mitochondrial ERK protects cancer cells from death through inhibition of the permeability transition
Andrea Rasola et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Functional Identification of Tumor-Suppressor Genes through an In Vivo RNA Interference Screen in a Mouse Lymphoma Model
Anka Bric et al.
CANCER CELL (2009)
The COX-2/PGE(2) pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment
Alexander Greenhough et al.
CARCINOGENESIS (2009)
Regulation of Prostaglandin Transporters in Colorectal Neoplasia
Vijaykumar R. Holla et al.
CANCER PREVENTION RESEARCH (2008)
Ras oncogenes: split personalities
Antoine E. Karnoub et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
ERK implication in cell cycle regulation
Jean-Claude Chambard et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2007)
Hyperactive Ras in developmental disorders and cancer
Suzanne Schubbert et al.
NATURE REVIEWS CANCER (2007)
Properties of the Group IV phospholipase A2 family
Moumita Ghosh et al.
PROGRESS IN LIPID RESEARCH (2006)
Proteomic analysis reveals field-wide changes in protein expression in the morphologically normal mucosa of patients with colorectal neoplasia
Abigael C. J. Polley et al.
CANCER RESEARCH (2006)
High frequency of mutations of the PIK3CA gene in human cancers
Y Samuels et al.
SCIENCE (2004)
PTEN mutations are common in sporadic microsatellite stable colorectal cancer
NT Nassif et al.
ONCOGENE (2004)
Downregulation of prostaglandin E receptor subtype EP3 during colon cancer development
Y Shoji et al.
GUT (2004)
Alteration of gene expression in normal-appearing colon mucosa of APCmin mice and human cancer patients
LC Chen et al.
CANCER RESEARCH (2004)
Targeting ras signalling pathways in cancer therapy
J Downward
NATURE REVIEWS CANCER (2003)
The phosphatidylinositol 3-kinase-AKT pathway in human cancer
I Vivanco et al.
NATURE REVIEWS CANCER (2002)
Acceleration of intestinal polyposis through prostaglandin receptor EP2 in ApcΔ716 knockout mice
M Sonoshita et al.
NATURE MEDICINE (2001)
Biology of the adenomatous polyposis coli tumor suppressor
KH Goss et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
分享论文
